Skip to content
Subscriber Only

Chinese Scientists Plan First Human Test With Gene Editing Tool

  • Group has recruited first patient in lung cancer trial
  • Early stage trial would only test if technology is safe
1469193721_GettyImages-1951595
Photographer: Mario Tama/Getty Images
Updated on

Chinese scientists are embarking on what appear to be the first human trials with the Crispr gene editing tool, the latest effort by the country’s researchers to master a technology that might someday be a potent tool in developing therapies worldwide.

The group led by Lu You, an oncologist at the south-western Sichuan University West China Hospital, has recruited the first patient for a ten-people clinical trial, which will activate immune cells using Crispr and infuse them back into patients to fight lung cancer. Due to potential risks in using the pioneering treatment for humans, the team has decided to treat the first group of three patients one at a time, Lu said in a phone interview.